Skip to main content

Peer Review reports

From: Clinical features with anti fibroblast growth factor receptor 3 (FGFR3) antibody-related polyneuropathy: a retrospective study

Original Submission
8 Oct 2020 Submitted Original manuscript
10 Nov 2020 Reviewed Reviewer Report
12 Nov 2020 Reviewed Reviewer Report
25 Nov 2020 Author responded Author comments - Elanagan Nagarajan
Resubmission - Version 2
25 Nov 2020 Submitted Manuscript version 2
3 Dec 2020 Reviewed Reviewer Report
18 Dec 2020 Reviewed Reviewer Report
15 Jan 2021 Author responded Author comments - Elanagan Nagarajan
Resubmission - Version 3
15 Jan 2021 Submitted Manuscript version 3
18 Jan 2021 Reviewed Reviewer Report
19 Jan 2021 Reviewed Reviewer Report
21 Jan 2021 Author responded Author comments - Elanagan Nagarajan
Resubmission - Version 4
21 Jan 2021 Submitted Manuscript version 4
29 Jan 2021 Author responded Author comments - Elanagan Nagarajan
Resubmission - Version 5
29 Jan 2021 Submitted Manuscript version 5
Publishing
2 Feb 2021 Editorially accepted
15 Feb 2021 Article published 10.1186/s12883-021-02090-2

You can find further information about peer review here.

Back to article page